Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development
- Written by PR Newswire
HMI-115 received FDA Fast Track Designation based on results from a Phase II clinical trial for endometriosis
Mean dysmenorrhea pain score reduced by 42%
Mean non-menstrual chronic pelvic pain score reduced by 52%
Most patients maintained normal menstrual cycles
No typical peri-menopausal symptoms were reported in patients
No significant changes in...
